Why SOAP Health Matters to Me,
& Should to All of Us

From our CEO, Dr. Steven Charlap
Dr. Steven Charlap and his brother

My older brother and me, circa 1960’s

Seven years ago, one of my older brothers, a practicing cardiologist, was diagnosed with two primary cancers a week apart. One year later he was gone. His cancer workup revealed he had a BRCA2 mutation, the gene mutation commonly associated with breast and ovarian cancer, but also associated with male breast, prostate, kidney, and pancreatic cancer, as well as melanoma. This should have come as no surprise given that my father’s two sisters, our aunts, and one of their daughters, his niece and our first-cousin, were all diagnosed with early breast cancer in their 30s, 40s, and 50s. In addition, our father was diagnosed with prostate cancer at age 79, alone not a major red flag. But it did surprise us because no physician had ever inquired about my brother’s and even till today, my now expansive (12 cases in all) family history of cancer. If a doctor had, and he or she understood the clinical significance of such early age cases of breast and other cancers on one side of the family, that doctor may have instituted increased surveillance, which could have found my brother’s cancers earlier when effective treatment may still have been possible.

Fortunately, I don’t have the mutation, not that any doctor has ever bothered to ask. However, it is ironic that my brother was diagnosed with hereditary cancer while I was the Chief Medical Officer of a primary prevention medical clinic in Florida and was widely touting the impact of lifestyle over genetics for living longer and healthier to tens of thousands of people through TV, radio and speaking presentations. My brother’s diagnosis gave me pause to reconsider my attitude toward genetic predispositions and a realization of the need to better understand the science. It also made me really ponder why doctors didn’t collect detailed family medical histories. After my brother passed, I closed my clinic and went to Stanford to gain that knowledge.

I then completed a National Science Foundation funded program that facilitated my interviewing 25 primary care physicians from Florida to New York to California. They described how hard pressed they are for time to collect detailed family histories and perform valid risk assessments. Basically, they shared that very few of them are collecting sufficient family history to fully assess early disease risk, and even among those trying to do so, the doctors admitted they are not doing it well. They collectively all know they need help if the situation is going to change and would be excited to embrace a solution that is clinically validated, integrated into their workflows, and easy for their patients to use.

With 12 million diagnostic errors made each year, the most common among them missing early cancers and heart diseases, which cost over 100,000 lost lives and $750 billion, Soap Health’s mission is clear: spare people from the pain and suffering of passing from or losing someone to a preventable or earlier identifiable genetic or lifestyle driven adult disease such as cancers and heart diseases, drive down malpractice suits, and improve physician productivity by augmenting physicians’ capabilities to perform in depth risk assessments and improve early disease detection and diagnosis.

Meet Our Team

SOAP Health has assembled an exceptional team with business, clinical, scientific and technical capabilities. The team includes an MD, MBA,  and PhD. Expertise includes scaling entrepreneurial businesses, engineering leadership, scientific research, consulting, and academia. Specific knowledge includes software development, company building, project management, virtual agents, algorithm development, computational science, and extensive health care industry insights.

Steven Charlap, MD
Steven Charlap, MDChief Executive
30+ year health care experience; MD, NYU, Surgeon; MBA, Harvard; Fellow, Stanford; co-founder HealthDrive (acquired), largest US medical/dental services provider to extended care industry, two-time Inc. 500 company (#73) – built first US mobile, multi-specialty electronic medical record system; co-founder MDPrevent, primary prevention medical services; Director of Corporate Development, T Cell Sciences, biotechnology (public; acquired); In Vitro Care (public); Visiting Scientist Harvard; Stanford Researcher/Grant Recipient; Multiple Startup Board Advisor; HBS and Stanford-wide Mentor
Sinhwa Kang, PhD
Sinhwa Kang, PhDDirector of Digital Humans
PhD in Communications, RPI Communications, USC Virtual Agent Researcher
12+ years research experience at USC with virtual agents and human-computer interaction in relation to healthcare applications
Rodrigo Lima
Rodrigo LimaChief Engineer
Manager and Software developer with 15+ years of experience, passionate about full-stack development with a focus on software quality and business value. An experienced leader and developer, having successfully worked with development teams, with leading positions, on different companies and technologies. Used to Agile methodologies and industry proven best practices in software development.

Jamie Lust
Jamie LustChief Strategy
20+ years of senior leadership at CNA, Allstate and Accenture with expertise in Transformation, Data Analytics, Technology, and Operations
David Ramoley
David RamoleyChief Client
19+ years of experience at Cerner leading customer facing teams responsible for implementation and integration.
Gustavo Maltez
Gustavo MaltezSoftware Developer
Graduating in Software Engineering, study and develop software since 14 years old. 3+ years of experience developing mobile, web and desktop applications using React.
Ricardo Grunitzki, PhD
Ricardo Grunitzki, PhDLead AI Engineer
10+ years AI experience with PhD in Computer Science, Professor, with expertise in ML, DL, CV, RL, and AI research experience at Sidia.


“The amount of information about genetics has become too large and complex for anyone clinician to understand and remember. Bringing the computer into the equation to decrease workload and improve the quality of care is a brilliant approach and needs to be taken advantage of.”

Physician Leader, Massachusetts General Hospital

“SOAP Health supports increased access to genetic counseling services by providing innovative ways to capture more patients at risk for hereditary cancer syndromes and can help streamline and simplify the genetic information and genetic testing process for patients and clinicians.”

Manager, Genetic Counselors

“Significant role in addressing a serious gap in medical care not only in family history and genetic testing but also in a number of other areas where informed/shared decision making is important.”

Chief Medical Officer, Health Advocacy Group

“The medical community would greatly benefit from a tool that helps collect detailed family history in a patient-friendly and cost-effective manner and provides decision-support as to what testing could benefit the patient.”

Professor and Physician, NYU Medical School

“I literally have seen thousands of innovative ideas and products and this is clearly one that has been well thought through and has such a potential to impact the live of patients literally everywhere giving them a realistic understanding of future health risks.”

VP of Innovation, Major Health Care System

“Physicians today don’t have the time or training to gather and analyze a detailed family history in order to determine which, if any, genetic tests would support the ultimate goal of providing their patients with the most precise and timely care. We are excited that SOAP presents a compelling solution to this problem. Not only will the tool help streamline the workflow of the patient visit it will also employ state-of-the-art patient engagement techniques to help collect accurate information on a complicated topic.”

CEO, Genetics Patient Advocacy Association

“The medical community would greatly benefit from a tool that helps collect detailed family history in a patient-friendly and cost-effective manner and provides decision-support as to what testing could benefit the patient.”

Researcher and Physician, Stanford Healthcare

“The promise of SOAP is that it is a tool that addresses barriers to implementation, e.g. improved physician workflow, clinical validity and utility, additional reimbursement, and seamless integration, and has the highest probability of finally bringing to market an eloquent solution that results in the appropriate screening of every at-risk patient, and their affected relatives.”

Genetic Counselor, Ohio State University

“A highly innovative and promising strategy for integrating cancer and heart disease genetic risk assessment into general medical practice.”

Associate Professor, Stanford Medicine

“SOAP Health has the potential to hasten the integration of genetic testing and risk assessment into regular clinical practice with significantly improved healthcare outcomes, while, importantly, reducing physician workload.”

Innovation Leader, Harvard

Sound too good to be true?

Request a Demo